MedTrace Logo

The Effects of Bifidobacterium Longum 1714® in a Population With Low Mood

NCT04925440 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2022-11-10

No results posted yet for this study

Summary

A randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of 8 weeks of supplementation with Bifidobacterium longum 1714® strain on Beck's Depression Inventory-II Score in adults who experience low mood.

Conditions

  • Low Mood
  • Depressive Symptoms

Interventions

DIETARY_SUPPLEMENT

Bifidobacterium longum 1714® strain

Probiotic capsules containing 5 x 10\^9 CFUs, corn-starch and magnesium stearate.

DIETARY_SUPPLEMENT

Placebo

Capsules containing corn-starch and magnesium stearate only.

Sponsors & Collaborators

  • Atlantia Food Clinical Trials

    collaborator INDUSTRY

  • PrecisionBiotics Group Ltd.

    lead INDUSTRY

Principal Investigators

  • Ted Dinan · Atlantia Food Clinical Trials

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-13
Primary Completion
2022-08-04
Completion
2022-08-19

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04925440 on ClinicalTrials.gov